| My Progress | Program Title | Credit Type | Therapeutic Area | Format |
|---|---|---|---|---|
| Effective Risk Stratification And Expert Treatment Selection Advice For Patients With Myelodysplastic Syndromes | Participation
CME
CNE
CPE
AANP
AAPA
|
Oncology | On-Demand Webcast | |
| Relapsed/ Refractory Multiple Myeloma: Novel and Cellular Therapies in 2023 | Participation
CME
CPE
AANP
AAPA
CNE
|
Oncology | On-Demand Webcast | |
| Optimal Frontline Therapy of Myeloma | Participation
CME
CNE
CPE
AANP
AAPA
|
Oncology | On-Demand Webcast | |
| What Are The Latest Strategies For Relapsed CLL And What Is On The Horizon? | Participation
CME
CPE
AAPA
AANP
CNE
|
Oncology | On-Demand Webcast | |
| Optimizing Myeloma Therapies For Older And More Frail Patients | Participation
CME
CPE
AANP
AAPA
CNE
|
Oncology | On-Demand Webcast | |
| How Do We Choose Among Non-CAR-T Options For Patients With Recurrent Aggressive Lymphoma | Participation
CME
AAPA
CNE
CPE
AANP
|
Oncology | On-Demand Webcast | |
| Antibody Drug Conjugates – Where And When To Use Them In Hodgkin Lymphoma | Participation
CME
AAPA
CPE
CNE
AANP
|
Oncology | On-Demand Webcast | |
| Targeted Treatment For Mantle Cell Lymphoma: Reimagining First-Line Therapy | Participation
CME
CNE
AAPA
CPE
AANP
|
Oncology | On-Demand Webcast | |
| First Line Treatment Of CLL/SLL With Bruton 's Tyrosine Kinase Inhibitors: Seeking Lasting Results | Participation
CME
CNE
CPE
AAPA
AANP
|
Oncology | On-Demand Webcast | |
| Managing Relapsed/Refractory Follicular Lymphoma: Novel Therapeutic Strategies Across Treatment Lines | Participation
CME
AAPA
CNE
CPE
AANP
|
Oncology | On-Demand Webcast |